Objectives: Abnormalities of the cardiovascular system, e.g. impaired vasoreactivity and changes in baroreflex control of heart rate, are known to occur in experimental diabetes. It is not clear whether these cardiovascular dysfunctions are direct consequences of cardiovascular deficits andror have autonomic neuropathy as a cause. Methods: To differentiate between cardiovascular deficits or neuronal impairment as a cause for these cardiovascular dysfunctions, we tested the effects of the ACTH analogue, Org 2766, a 4 -9 neurotrophic compound without cardiovascular effects, on arterial pressure, heart rate and baroreflex control of heart rate. At 15 weeks, rats were made diabetic by injection of streptozotocin, and from 0-6, 6-12 or 12-18 weeks thereafter 3 groups of rats were treated with Org 2766. These effects were evaluated during phenylephrine-induced increases, and sodium nitroprusside-induced decreases, in blood Ž . pressure, in rats that had been diabetic for various periods 2-42 weeks . Results: Throughout, both depressor response and maximal Ž . vasodilator activity in response to sodium nitroprusside were significantly P -0.05 reduced as compared to those of the non-diabetic Ž . controls. The pressor response of the diabetic rats to phenylephrine was only significantly P -0.05 reduced at 4, 6 and 12 weeks, and at 18 weeks, the diabetic rats were either hypo-or normoresponsive; Org 2766 did not restore the disturbed pressor response. From weeks 4 to 42 both maximal decrease in heart rate and sensitivity of baroreflex-mediated bradycardia in the diabetic rats were significantly less Ž . P -0.05 than those in the non-diabetic controls. Org 2766 restored the diminished baroreflex-mediated bradycardia of diabetic rats to non-diabetic control levels at 6 weeks, had an ameliorating effect at 12 weeks and no effect at 18 weeks. Conclusions: Time-dependent decreases in baroreflex sensitivity in diabetic rats was demonstrated and a much less steep decline of baroreflex sensitivity occurred in non-diabetic control rats. The ACTH analogue, Org 2766, when given immediately upon the induction of diabetes seem to delay the 4 -9 development of autonomic neuropathy, which suggests that cardiovascular factors appear to be of minor importance. q 1998 Elsevier Science B.V. All rights reserved.
Introduction
Cardiovascular dysfunctions are a major cause of death in patients with diabetes mellitus. Vascular pathology, e.g. w x w x atherosclerosis 1 and microangiopathy 2 could play a role in the aetiology of these dysfunctions. However, these patients are also commonly afflicted with peripheral neuropathy. Diabetic neuropathy can affect both somatic and autonomic nervous systems. Autonomic neuropathy might cause profound disturbances of cardiovascular control ) Ž .
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Ž w x . mechanisms see Ref. 3 for review . However, the contribution of this autonomic neuropathy to cardiovascular disease in patients with diabetes mellitus is not yet clear.
In experimental diabetes, abnormalities of the cardiovascular system are known to occur, e.g. impaired responsiveness of the vasculature to vasoactive agents and changes Ž w x in the baroreflex control of heart rate see Ref. 4 for . review . Whether these cardiovascular dysfunctions are a Ž consequence of direct cardiovascular deficits i.e. abnormalities of the heart and vasculature apart from neural . Ž . defects andror of autonomic neuropathy indirect is still Time for primary review 27 days.
0008-6363r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved. unknown. Earlier studies, that showed cardiovascular dysfunctions in diabetic rats, demonstrated a disturbed sympathetic innervation of blood vessels, which might underlie w x hyporesponsiveness of blood pressure 5 and of macrocirw x w x culatory 6 and microcirculatory neuronal blood flow 7 to sympathoadrenergic stimuli in diabetic rats. Most of the in vitro and in vivo studies of vasoreactivity concerned the early phase of streptozotocin-induced diabetes and little is w x known about its long-term effects on vasoreactivity 8 .
The baroreflex control of heart rate has been found to be altered in rats with streptozotocin-induced diabetes w x w x 9-14 , in diabetic BBrWor rats 15 and in diabetic w x rabbits 16 . Findings regarding baroreflex-mediated bradyw x cardia in diabetic animals are contradictory 10, 13, 15, 16 . Likewise, the reflex tachycardia seen during decreases in arterial pressure in diabetic animals was found to be either w x w x pronounced 15 or normal 14, 16 . Interestingly, Chang w x and Lund 12 concluded that, in diabetic rats, baroreflex activity changes as diabetes progresses. These results raise the possibility of time-dependent alterations in cardiovascular control mechanisms in experimental diabetes.
The purpose of the present study was to investigate the vasoreactivity and baroreflex control of heart rate over time in diabetic rats, when altered reflex bradycardia was found, additional experiments were done with the ACTH analogue, Org 2766, to differentiate between an 4 -9 autonomic neuronal or a direct cardiovascular origin of the alterations in vasoreactivity and baroreflex control of heart rate. The ACTH analogue, Org 2766, does not have a 4 -9 w x direct effect on the cardiovascular system 17 and has been shown to be effective in peripheral nerve disorders in w x both rats and humans 18 . In addition, Org 2766 can have neurotrophic and neuroprotective effects on the autonomic w x nervous system of the experimentally diabetic rat 6,7 .
Methods

Animals and induction of experimental diabetes
Male U:WUrCPB-Wistar rats weighing approximately Ž . Ž 295 g age 15 weeks were housed in Macrolon cages two . rats per cage . Diabetes mellitus was induced by a single Ž . i.v. injection of streptozotocin Serva, 40 mgrkg . Rats with blood glucose levels higher than 15 mmolrl as w x measured by an Ames Glucose Test Pack 6,7 were considered diabetic. They were maintained on a 12-h Ž . lightrdark cycle light on at 7.00 h . All rats received water and standard rodent chow ad libitum. The non-di-Ž abetic control rats were given a food-restricted diet 14 g . rat chowr24 h with the calorie intake adjusted to keep their body weights similar to those of diabetic rats. All experimental protocols were approved by the Ethical Committee on the use of experimental animals of the Faculty of Medicine of Utrecht University.
Preparation and measurements
General
Surgery was performed on animals anaesthetized with Ž . urethane 10% dissolved in 0.9% NaCl solution injected i.p. in a dose of 1.2 mlr100 g body weight. Urethane was used instead of barbiturates in order to ensure minimal w x anaesthetic interference with the cardiovascular system 6 . Body temperature was recorded with a rectal probe, and maintained at 378C with a homeothermic blanket system Ž . Harvard Apparatus .
( ) 2.2.2. Experiment I time-effect relationship
Ž . Indwelling catheters polyethylene tubing, Intramedic were inserted into the right femoral vein and right femoral artery to record direct blood pressure and heart rate, and to administer drugs. Arterial blood pressure and heart rate were measured by means of a Viggo-Spectramed DTXrplus transducer connected to a preamplifierrbio-Ž . tachometer system University of Utrecht . All the data Ž were processed with a Bio Signal Processing System Instrumental services, University of Limburg, Maastricht, . The Netherlands and a Wekagraph WK-821 AR recorder. The collected data were processed with a Compaq Deskpro 386r20 MHz computer and were determined once per 500 ms. The mean arterial blood pressure was calculated using Ž the formula: MAP s 2 = diastolic blood pressure q . systolic blood pressure r3. Initial haemodynamic values were estimated after a 15-min stabilisation period. To elicit Ž . baroreflexes, phenylephrine reflex bradycardia at doses Ž of 0.3-30 mgrkg and sodium nitroprusside reflex tachy-. cardia at doses of 0.1-10 mgrkg were administered as bolus injections through the femoral vein. The injection volume, 100 ml, was found to have no haemodynamic effects when saline was used. Heart rate and blood pressure were allowed to return to baseline values before the next dose of a drug was administered. A resting period of 15 min was allowed between the highest dose of phenylephrine and the lowest dose of sodium nitroprusside. Heart rate and blood pressure were recorded continuously throughout the procedure.
( ) 2.2.3. Experiment II effects of Org 2766
At weeks 6, 12 and 18 after the induction of diabetes the rats were fitted with indwelling arterial and venous cannulae to record direct blood pressure and heart rate, and Ž . to administer phenylephrine see Section 2.2.2 . The experimental groups are detailed in 'Outline of the study'. 4 -9 and reflex bradycardia was investigated at different times during the induction of diabetes. Series I: group 1, the non-diabetic control rats were given a food-restricted diet for 6 weeks; group 2, diabetic rats were given the ACTH 4 -9 analogue, Org 2766, 75 mgrkg in 0.5 ml saline s.c. every 48 h; group 3, diabetic rats were given placebo, 0.5 ml saline s.c. every 48 h. The treatment of groups 2 and 3 was started immediately after the injection of streptozotocin and continued for 6 weeks. Series II: the second series followed the same protocol as the first series. However, Ž . the treatment of groups 2 and 3 see above was started 6 weeks after the streptozotocin injection, when experimenw x tal diabetic neuropathy was manifest 19,20 and was continued for 6 weeks, up to 12 weeks. Series III: the third series followed the same protocol as the second series. However, the treatment with the ACTH analogue, Org 4 -9 2766, and placebo was started 12 weeks after the induction of diabetes and was continued for 6 weeks, up to 18 weeks.
Drugs
Data analysis
The data are presented as means " s.e.m. The significance of differences in initial haemodynamic variables and maximal changes in heart rate and mean arterial pressure between two groups was assessed with Student's t-test and differences between more than two groups were assessed Ž . by analysis of variance ANOVA , followed by the Student-Newman-Keuls test. The significance of differences between groups for dose-response curves to vasoactive drugs was assessed by a multivariate analysis of variance 
Ž
. with repeated measurements MANOVA . The 'ramp' w x technique was used to construct baroreflex curves 21 . Use of this technique allowed the sensitivity of the baroreflex control of heart rate to be calculated by linear regresw x Ž sion 22 . The regression coefficient slope of the regres-. sion line was taken as an index of baroreflex sensitivity w x 21 and the difference in slopes for the response to treatment between two groups was evaluated with Student's t-test. Differences between more than two groups were assessed by an ANOVA, followed by the Student-Newman-Keuls test to assess differences between groups. The mean average correlation coefficients were always ) 0.85 and usually ) 0.90. The changes in dose-response curves relationships were calculated at the time of maximal effect as compared to preinjection values. A P-value of less than 0.05 was accepted as indicating a significant difference.
Results
Experiment I: general features and initial haemodynamic Õalues
All rats that received streptozotocin became diabetic. The blood glucose levels remained over 15 mmolrl Ž . throughout the study Table 1 . The body weights of diabetic rats were significantly lower than those of non-di-Ž . abetic controls at 2, 4 and 12 weeks of diabetes Table 1 Ž . response to phenylephrine administration in the diabetic rats v was Ž . Ž . significantly smaller than in the non-diabetic controls I P -0.05 . At 34 weeks, the MAP response to phenylephrine administration was the same for both groups.
rized in Table 1 . The mean arterial blood pressure of diabetic rats was significantly lower than that of non-di-Ž . abetic control rats P -0.05 at 12, 18 and 42 weeks after the induction of diabetes. There were no significant differences in heart rate between the diabetic and non-diabetic group at any time.
Experiment II: general features and initial haemodynamic Õalues
All rats in the three series which received streptozotocin became diabetic. The blood glucose levels of these diabetic rats remained above 15 mmolrl throughout the experimen-Ž . tal period data not shown . The mean body weights of the non-diabetic rats and of the diabetic rats are given in Table  2 . After 6 weeks of treatment, there was no difference between the blood glucose levels and body weights of the Org 2766-treated diabetic rats and those of the placebotreated diabetic rats. The data for the initial haemodynamic variables are summarized in Table 2 . The mean arterial blood pressure of the placebo-treated and Org 2766-treated groups was not significantly different from the mean arterial pressure of the non-diabetic control group after 6, 12 and 18 weeks of diabetes. Neither systolic nor diastolic blood pressure differed significantly among the three experimental groups after 6, 12 and 18 weeks of diabetes. The heart rate was not significantly different between any Ž . of the experimental groups at any time Fig. 1 . At all time points, the maximal vasodilator activity of sodium nitro-Ž . prusside 10 mgrkg in the diabetic rats was significantly Ž . less P -0.05 than that in the non-diabetic control rats Ž . Fig. 2 . At all time points, the changes in heart rate in response to sodium nitroprusside-induced decreases in blood pressure were slight in both the diabetic and the non-diabetic rats. Even at the dose of 10 mgrkg sodium nitroprusside the change in heart rate was slight for both groups. The non-diabetic control rats always showed a slight tachycardia, whereas the heart rate response of the diabetic rats was variable. At all time points the blood pressure-heart rate relationship for both groups was not Ž . significantly linearly correlated P ) 0.05 and, therefore, no baroreflex-mediated tachycardia could be obtained. Fig. 3 . From weeks 4 to 42 the maximal decrease in heart rate due Ž . to phenylephrine was significantly smaller P -0.05 in Ž the diabetic rats than in the non-diabetic control rats Fig. .
. The blood pressure increasing efficacy of phenyl-
Ž . ephrine 30 mgrkg was similar throughout time age in Ž . diabetic and non-diabetic rats Fig. 4 . The slopes for the blood pressure-heart rate relationship during phenylephrine-induced increases in blood pressure, reflecting Ž baroreflex sensitivity, were significantly decreased P -. 0.05 compared to those for non-diabetic control rats at the various points after induction of diabetes. After 2 weeks, however, the baroreflex sensitivity was not significantly Ž . different between the two groups Table 3 .
( ) 3.4. Experiment II: Õaso de pressor responses and baroreflex function
At weeks 6, 12 and 18 the mean arterial blood pressure response to phenylephrine in the placebo-treated diabetic rats was significantly reduced compared to the response of Ž . the non-diabetic control rats P -0.05 . The response of mean arterial blood pressure to phenylephrine, however, was the same in the Org 2766-treated diabetic rats and in the placebo-treated diabetic rats. At weeks 6, 12 and 18, the heart rate response to phenylephrine was significantly less in the diabetic rats than in non-diabetic control rats Ž . P -0.05 and Org 2766 had no influence on this re-Ž . sponse. At weeks 6, 12 and 18 the sensitivity slope of the baroreflex bradycardia curves elicited with phenylephrine in the placebo-treated diabetic rats was significantly less Ž .Ž . than the slope from non-diabetics P -0.05 Table 2 . At 6 weeks, the slope of the baroreflex bradycardia curves of the Org 2766-treated diabetic rats was similar to that of the Ž . non-diabetic control rats Table 2 and Fig. 5 . At 12 weeks, the slope of the baroreflex bradycardia curves of Ž . Ž . Fig. 5 . Left panel: baroreflex control of heart rate HR determined from the phenylephrine-induced increases in mean arterial blood pressure MAP after Ž . Ž . Ž . 6 weeks of diabetes in the placebo-treated diabetic rats v , the Org 2766-treated diabetic rats`and the non-diabetic control rats I . The Org 2766-treated animals were treated from weeks 0 to 6 after being made diabetic. The slope of the baroreflex bradycardia curves of the Org 2766-treated Ž . diabetic rats was similar to that of the non-diabetic control rats and differs significantly from placebo-treated diabetic rats P -0.05 . Right panel:
Ž . baroreflex control of HR determined from the phenylephrine-induced increases in MAP after 12 weeks of diabetes in the placebo-treated diabetic rats v , Ž . Ž . the Org 2766-treated diabetic rats`and the non-diabetic control rats I . The Org 2766-treated animals were treated from weeks 6 to 12 after being made diabetic. The baroreflex-mediated bradycardia of the placebo-treated diabetic rats was significantly less than that of both the non-diabetic control rats Ž . and the Org 2766-treated diabetic rats P -0.05 . the Org 2766-treated diabetic rats was increased as com-Ž . pared to that of the placebo-treated diabetic rats P -0.05 , however, Org 2766 treatment could not completely restore Ž . this slope to the value for non-diabetic controls P -0.05 Ž . Table 2 . The blood pressure-heart rate relationship for the three groups 12 weeks after the induction of diabetes is shown in Fig. 5 . At 18 weeks, the slope of the baroreflex bradycardia curves for the placebo-treated diabetic rats and Ž . Org 2766-treated diabetic rats was the same Table 2 .
Discussion
Abnormalities of the cardiovascular system, e.g. impaired responsiveness of blood pressure to vasoactive agents and changes in baroreflex control of heart rate, are known to occur in experimental diabetes. It is not clear whether these cardiovascular dysfunctions are direct consequences of cardiovascular deficits andror have autonomic Ž w x . neuropathy as an indirect cause see Ref. 4 for review .
There are conflicting data for blood pressure in experiw x w x mental diabetes. Hypotension 12 , hypertension 23 and w x normotension 12 have been reported. We recently found that relatively short-term diabetic rats were normotensive w x 6,7,20,24 . In the present study, we found both hypotension and normotension in the relatively short-term diabetic rats. Our experimental approach for measuring blood pressure having been the same for both the earlier and the present experiments, we cannot explain these differences. Differences in rat strain, duration of diabetes, anaesthesia or techniques for measuring blood pressure could explain w x the conflicting data 25 .
The vasodilator, sodium nitroprusside, elicited in our anaesthetized control rats, a depressor response comparaw x ble to what had been measured in conscious rats 15 . Despite the clear depressor response, only minimal reflex tachycardia was elicited. The absence of a consistent, clear, reflex tachycardia in the present study might be w x ascribed to the urethane anaesthesia. Stornetta et al. 26 found that urethane attenuated the tachycardiac response to a decrease in blood pressure and had only a slight effect on the bradycardiac response to an increase in blood pressure when compared to the cardiac response in conscious rats. It seems that urethane anaesthesia in rats decreases sympathetic stimulation by sodium nitroprusside. The variable heart rate response to sodium nitroprusside in diabetic rats might be a consequence of the depressed vasoreactivity. Also, the underlying diabetic process could have interfered Ž . Ž with the baroreflex arc see below . We unpublished . observations and others have found a diminished vasodilator response to vasodilator agents with different modes of w x action in diabetic rats 27, 28 . There thus appears to be a general loss of vasodilator reserve, which we found to be present as early as after 2 weeks of diabetes and to persist up to 42 weeks. However, other authors have found that the endothelium-independent relaxation to nitrovasodilators is unaffected by diabetes especially in in vitro studies w x 29,30 . The method used in in vitro studies provides a defined endogenous postsynaptic stimulus, whereas the response to exogenously applied vasoactive agents in in vivo studies may be complicated by factors other than those directly determining vasoreactivity.
Phenylephrine, as ' vasopressor', elicited a pressor response in the diabetic rats which was decreased during the relatively early stages, but returned toward its control levels after long-continued exposure to diabetes, indicating a change in vasoreactivity. Alterations in vasoreactivity to phenylephrine may thus depend upon the length of time the animals have been exposed to the diabetes. The hyporesponsiveness to phenylephrine was evidence of postsynaptic defects, confirming other findings of decreased w x sympathoadrenergic responsiveness 10,20 . There is, however, no general agreement as to the effect of diabetes on vasoreactivity, and little is known of the effects of longterm streptozotocin-induced diabetes on blood pressure Ž w x responsiveness to sympathoadrenergic stimuli see Ref. 8 . for review . As the ACTH analogue, Org 2766, had no 4 -9 effect on the hyporesponsiveness of the pressor response in diabetic rats, and has beneficial effect on the presynaptic w x autonomic nerve fibres 6,7,24 , but no direct cardiow x vascular effects 17 , the decreased vasoreactivity to phenylephrine appears to have a direct vascular origin.
In our anaesthetized control rats, the increases in mean arterial blood pressure evoked by i.v. phenylephrine were associated with a distinct reflex bradycardia which was in w x the same range as that measured in conscious rats 15 . Our w x data and those of others 21,22 have shown that the blood pressure-heart rate relationship is linear when increases in mean arterial blood pressure up to 65 mmHg are evoked by phenylephrine. The sensitivity of the blood pressureheart rate relationship was only decreased at 2 weeks of diabetes, while the decrease in sensitivity of the baroreflex-mediated bradycardia in the diabetic rats appeared at all measurements made subsequently. The baroreflex control of heart rate has been found to be altered in streptozow x tocin-induced diabetic rats 9-14 , in diabetic BBrWor w x w x rats 15 and in diabetic rabbits 16 . Some of these results for baroreflex activity must, however, be interpreted with w x caution 9,11 because the pressor agents used may have had direct cardiac effects which interfered with the reflex bradycardia. There are conflicting results for baroreflexw x mediated bradycardia. An increase 10,13,14 , a decrease w x w x 16 and no alteration 13,15 have been reported. Only one study, so far, has measured baroreflex control of heart rate in response to pressor stimuli in long-term experimental w x diabetes 12 . The authors reported an increase in baroreflex control of heart-rate sensitivity during the early stages of diabetes, which returned to its control levels and ultimately after long-term exposure to diabetes, a decrease in sensitivity was measured. We could not confirm these time-dependent alterations in baroreflex control of heart Downloaded from https://academic.oup.com/cardiovascres/article-abstract/38/3/763/327611 by guest on 13 December 2018 ( )rate. Alterations of the integrated neural control of cardiac function might involve both the cardiac parasympathetic w x and sympathetic systems 31-33 . The impairment of the baroreflex-mediated bradycardia might be due to decreased w x sensitivity of baroreceptor afferents 34 , to impaired actiw x vation of central parasympathetic pathways 14,35 , or to impaired vagal efferent neural control of the heart rate w x w x 12,16 . McDowell et al. 36 found that a defect in the activation of central parasympathetic pathways could be responsible for the impairment of the baroreflex control of heart rate in diabetic rabbits. Similar experiments with induced-diabetic rats could help identify the exact site of impairment of the baroreflex arc. Our present results do not allow identification of the site of impairment of the baroreflex arc.
In the present study, the ACTH analogue, Org 2766, 4 -9 was able to restore the diminished baroreflex-mediated bradycardia of diabetic rats to the non-diabetic control levels at 6 weeks, had an ameliorating effect at 12 weeks and no effect at 18 weeks after the induction of diabetes. Ž . These ameliorating effects can only be ascribed to neurow x protective effects 18 and not to haemodynamic actions of w x Org 2766 which this ACTH analogue lacks in rats 17 .
-9
w x Van der Zee et al. 5 found that the responsiveness to noradrenaline within the cardiovascular system was decreased in diabetes mellitus, and can be restored by Org 2766. In addition, Org 2766 had no effect on postsynaptic w x defects in diabetic rats 7 , and, as far we know, there is no evidence for any effect of Org 2766 on catecholamine release, synthesis or metabolism. It seems that Org 2766 exerts its protective and beneficial action on presynaptic Ž . para sympathetic nerve fibres in the streptozotocin-induced diabetic rat. It is suggested that exogenous melanocortins mimic or amplify a naturally occurring ACTH-like peptide signal in the repair process that is part w x of the regeneration repertoire 18 . The site of action of Org 2766 in the baroreceptor heart-rate reflex arc could be at the afferent, central or at the efferent level of the reflex Ž . pathway see above . The partial character of the restoration by Org 2766 of the baroreflex-mediated bradycardia might imply that non-neuronal, i.e. direct cardiovascular, alterations could also play a role in the impairment of the w x baroreflex pathway seen in experimental diabetes 37, 38 . w x Litwin et al. 37 found an abnormal cardiac function in diabetic rats. They mentioned that the alterations in ventricular relaxation and passive-elastic properties in the heart of diabetic rats might lead to loss of normal barore-Ž . flexes. On the other hand, micro angiopathy could lead to injury to the microvascular endothelium, and thus causes adaptive microvascular sclerosis, contributing to a loss of w x autoregulatory capacity 38 . Other non-neuronal explanations for the altered baroreflex-mediated bradycardia seen in streptozotocin-induced diabetic rats might be glycow x protein-induced ventricular stiffness 39 and alterations in w x sinoatrial nodal electrical activity 40 , the latter possibly w x being due to changes in calcium metabolism 41 .
In conclusion, time-dependent decreases in baroreflex sensitivity in diabetic rats was demonstrated and a much less steep decline of baroreflex sensitivity occurred in aging non-diabetic control rats. Furthermore, it can be concluded that cardiovascular factors do not contribute to the diminished baroreflex sensitivity in diabetic rats as the blood pressure increasing of phenylephrine seems to be quite similar throughout time in these rats. In fact, the reflectory heart rate responses are consistently decreased. Therefore, the vasoconstrictor effect of phenylephrine is well conserved, but the baroreflex pathway is impaired. The ACTH analogue, Org 2766, when given immedi-
